Genalyte, Inc.

Genalyte, Inc. is a life sciences company based in San Diego, California, founded in 2007. The company specializes in silicon photonic biosensor technology, which enables rapid, point-of-care blood testing. Their flagship product, Merlin, is a compact diagnostic system that processes whole blood samples in 15-30 minutes, providing lab-quality results directly in physicians' offices. This system integrates with electronic medical records for seamless operation. Genalyte focuses on multiplexing technology to analyze multiple proteins from a single drop of blood. Their diagnostic applications include tests for autoimmune diseases, COVID-19 antibodies, Type 1 Diabetes autoantibodies, and cancer-associated immune responses. The company aims to enhance the doctor-patient relationship by delivering immediate results and reducing inefficiencies in traditional lab processes. With a team of experienced leaders and a commitment to innovation, Genalyte is actively developing its technology and expanding its applications.